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ABSTRACT
Background England’s National Chlamydia Screening
Programme (NCSP) provides opportunistic testing for
under 25 year-olds in healthcare and non-healthcare
settings. The authors aimed to explore relationships
between coverage and positivity in relation to
demographic characteristics or setting, in order to inform
efficient and sustainable implementation of the NCSP.
Methods The authors analysed mapped NCSP testing
data from the South East region of England between
April 2006 and March 2007 inclusive to population
characteristics. Coverage was estimated by sex,
demographic characteristics and service characteristics,
and variation in positivity by setting and population
group.
Results Coverage in females was lower in the least
deprived areas compared with the most deprived areas
(OR 0.48; 95% CI 0.45 to 0.50). Testing rates were lower
in 20e24-year-olds compared with 15e19-year-olds
(OR 0.69; 95% CI 0.67 to 0.72 for females and OR 0.67;
95% CI 0.64 to 0.71 for males), but positivity was higher
in older males.
Females were tested most often in healthcare services,
which also identified the most positives. The greatest
proportions of male tests were in university (27%) and
military (19%) settings which only identified a total of
11% and 13% of total male positives respectively. More
chlamydia-positive males were identified through
healthcare services despite fewer numbers of tests.
Conclusions Testing of males focused on institutional
settings where there is a low yield of positives, and
limited capacity for expansion. By contrast, the testing of
females, especially in urban environments, was mainly
through established healthcare services. Future
strategies should prioritise increasing male testing in
healthcare settings.
INTRODUCTION
Genital chlamydial infection (chlamydia) is the
commonest sexually transmitted infection diag-
nosed in England. The prevalence among those
accepting screening in England in 2006/2007 was
over 10% in males and females aged 16e24.1
Complications associated with chlamydia include
pelvic inﬂammatory disease, which can lead to
infertility and ectopic pregnancy.2
England began to roll out its National Chlamydia
Screening Programme (NCSP) in 2003, with testing
occurring throughout the country by 2007. The
NCSP targets sexually active males and females
aged under 25 years through opportunistic
screening within both healthcare settings
(excluding GUM) and non-healthcare settings.3 It
differs from a national pilot programme4 and from
the chlamydia screening studies (ClaSS)5 in having
less reliance on primary care, and to date coverage
rates regionally and nationally have not been
comparable with the pilot which achieved testing of
50% of the target female population in Portsmouth
and 39% in Wirral in a 1-year period.4 Modelling
studies on chlamydia screening in England also
demonstrated that not only does coverage have to
be high but also it is important that populations
known to have higher positivity are effectively
targeted.6
The data from the ﬁrst year of the NCSP (April
2003eMarch 2004) have been reported, including
positivity by both behavioural and demographic
variables.7 While females 16e19 had comparable
positivity to 20e24-year-olds, among males aged
16e19, positivity was lower than in those aged
20e24.7 Individuals of black ethnicities showed
a higher positivity than white ethnicities. Testing
volumes were highest in contraceptive clinics,
youth services and general practice where positivity
was at least 8.3% in females and 7.6% in males.
Universities contributed 3% of female tests and 25%
of male tests with a positivity of 5.0% and 4.7%
respectively.
Prior to the NCSP, chlamydia diagnoses were
shown to be higher in more deprived areas, and this
was not explained by differential testing rates.8
Modelling studies estimate that the NCSP needs to
screen at least 36% of sexually active individuals
under 25 years annually to deliver its anticipated
health beneﬁts.6 Including males in the model
results in a greater and faster reduction in preva-
lence but requires considerably more testing.
Inequalities in coverage, if the most at risk were less
likely to be tested, may result in a less efﬁcient and
equitable outcome of the screening programme.8
In this study we explored coverage and positivity
of tests within the NCSP within the South East
region of England, in relation to demographic
characteristics and settings, in order to inform
equitable implementation of the programme.
METHODS
Over 8.3 million individuals are resident in the
South East region of England, whom 11% belong to
the 16e24-year-old age group eligible for chlamydia
screening. South East England surrounds London to
the South and West, and contains both rural and
urban districts.9 We analysed NCSP anonymised
testing data over a 1-year period (April 2006eMarch
2007), including all individuals under 25 years old
tested through the programme within the South
East region of England.
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The anonymised data available to us included test result, sex,
postcode of residence, ethnicity, result, age in years and clinic
type. We used the 2006 National Administrative Codes Service
Postcode Directory10 to map postcodes to administrative geog-
raphies based on population size, called Lower Super Output
Areas (LSOA), of which populations estimates are also available,
in order to estimate coverage. Not all tests mapped to the South
East, and these were categorised into three groups: postcodes
within the South East; postcode outside the South East; and
postcode not able to be mapped (including those where the
postcode was blank or incorrect).
South East postcodes were then subcategorised into screens
with postcodes identical to the clinic where they were tested
and others.
Mappable South East postcodes were assigned to urban/rural
areas category using the Postcode Directory. Areas were classed
as urban if they were within a settlement with at least 10 000
people, and rural if under 10 000.
The 2007 English Indices of Multiple Deprivation (IMD) is
derived from 37 different indicators which cover: Income,
Employment, Health and Disability, Education, Skills and
Training, Barriers to Housing and Services, Living Environment
and Crime. These are weighted and combined to create the
overall IMD 2007 rank for all LSOAs throughout the country.11
LSOAs within the South East region were split into quintiles
according to their national rank for both the coverage and posi-
tivity analyses. For the coverage analyses, the urban/rural vari-
able was assigned at LSOA level; where both urban and rural
postcodes were represented, the mode was taken, and if equal,
urban was assigned.
The setting of each test was assigned to healthcare or non-
healthcare settings according to NCSP guidance at that time.3
Healthcare includes accident and emergency (which also includes
minor injuries and walk-in centres), community contraceptive
services, general practice, gynaecology and obstetrics, pharmacy,
prison, sexual health services and termination of pregnancy. Non-
healthcare settings include chlamydia screening ofﬁces, military,
outreach, postal kits, universities (including colleges and schools)
and youth services.
Ethics review and data protection
The analysis was undertaken as a service evaluation by the
Health Protection Agency which manages the NCSP and holds
its dataset. As such, no separate ethical review was required. The
project was approved by appropriate senior managers, and
standard procedures for secure handling of data on internal
secure servers within the HPA were followed, with no identiﬁ-
able, pseudo-anonymised data of postcode data being transferred
outside the HPA.
Testing coverage analyses within the NCSP
The Ofﬁce of National Statistics provided mid-2005 population
estimates for LSOAs by sex and for the age groups 15e19 and
20e24.12 Counts of tests within each LSOA, by age group and
sex, were generated. Poisson regression was then used to estimate
incident rate ratios for testing coverage by age group, urban/rural
location and deprivation stratiﬁed by sex. This assumes that
a Poisson distribution, that is all events, in this case tests, are
independent. The individuals tested who had a postcode that
could not be mapped or who were resident outside the South
East were excluded.
Where a postcode of residence is identical to the clinic in
which the test was taken, it may not be a true residential
postcode (eg, university testing events). This could result in an
over-representation of individuals living in or attending estab-
lishments (eg, university residence, military bases) on a non-
permanent basis, since these individuals would not be counted
within population estimates. We therefore examined coverage at
LSOA level excluding tests with a postcode of residence identical
to the clinic postcode, in order to determine whether these tests
skewed the distribution and should therefore be removed from
coverage analyses.
Positivity analyses
Positivity was deﬁned as the proportion of tests with a positive
result recorded. Logistic regression was used to identify possible
explanatory variables for positivity within this dataset. Multi-
variate analyses for separate male and female analyses included
all variables that were shown to have an association with
positivity with a p value of less than 0.15 in univariate analyses
for either sex. Setting was derived from clinic types and so was
not included in multivariate analyses.
The multivariate models in this study were used to describe
testing and positivity with respect to a number of variables, not
to inform a predictive model, and investigating possible inter-
actions or effect modiﬁcation between variables was not within
the scope of this study.
RESULTS
Data on 26 146 tests were available. The demographic and
geographic distribution of those tested is shown in table 1.
Twenty-ﬁve per cent of all tests were in males and 75% in
females. The majority of all tests were in the 16e19-year age
group (58% of male tests, 53% of female tests), followed by the
20e24-year age group (37% male, 38% female) and then the
under-16-year-olds (5% male, 10% female). In both sexes, 12% of
tests could not be mapped to the postcode directory.
The most common clinic types for testing of females were
community contraception services (35%), youth services (22%)
and general practice (17%). For males, the most common clinic
types were universities (27%), military (19%) and youth services
(16%). More tests were done in healthcare than in non-
healthcare settings for females (59%), but the reverse was true
for males (28%).
Coverage of testing within the South East NCSP
As shown in table 2 1.0% of males and 3.3% of females aged
15e24 were tested. Compared with 15e19-year-olds, both males
and females aged 20e24 were less likely to be tested (IRR 0.67,
95% CI 0.64 to 0.71 for males; IRR 0.69, 95% CI 0.67 to 0.72 for
females).
As shown in table 1, 28.1% of tests in males had a postcode
that was identical to the postcode of the clinic where the sample
was taken, whereas for females this accounted for only 3.8% of
tests. In some LSOAs, coverage was almost 200% and was clearly
inaccurate at this low level of geography. Of these tests in males,
the clinic types reporting the highest numbers were military
(1045; 57.5%), universities (326; 18.0%), general practice (295;
16.2%) and prison (76; 4.2%). These poorly documented tests
therefore are most likely to bias estimates where military and
universities are located and were removed for the analyses of
coverage by urban/rural status and IMD (both of which are also
assigned by postcode) for both males and females.
Testing coverage was lower in rural areas than urban centres
for males and females, with IRRs 0.77 (95% CI 0.70/0.84) and
0.60 (95% CI 0.57 to 0.63) respectively. For females, testing
coverage shows an increase in a linear relationship with IMD
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and the incident rate ratio of being tested in the least deprived
compared with the most deprived category was 0.48 (95% CI
0.45 to 0.50). For males, the association between testing
coverage and deprivation (IMD) is not linear but rather is U-
shaped, with the middle categories of deprivation having the
lowest coverage.
Positivity of tests by population subgroup
Overall positivity was 7.4% in males and 8.8% in females
(table 3). Univariate analyses showed evidence of associations
between positivity and all variables of interest, except for urban/
rural location in males. All variables were therefore included in
the models of testing positivity.
For males, positivity was highest in 20e24-year-olds (8.6%),
while both 16e19 and <16 age groups showed a lower positivity
with an adjusted OR (AOR) of 0.62 (95% CI 0.49 to 0.79) and
0.21 (95% CI 0.10 to 0.45) respectively after accounting for other
variables. Positivity in 20e24-year-old females was 7.6% and,
in contrast to males, was similar to 16e19-year-olds (AOR
1.04, 95% CI 0.92 to 1.17) and similarly to males was lower in
<16-year-olds (AOR 0.46, 95% CI 0.36 to 0.60).
Positivity was higher in black males compared with positivity
in white ethnicities (AOR 2.15, 95% CI 1.40 to 3.29) but lower
in females of Asian ethnicities (AOR 0.26, 95% 0.08 to 0.82).
Males living in less deprived areas were less likely to test
positive than males in more deprived areas (AOR 0.63 95% CI
0.43 to 0.92). Crude ORs for testing positivity in males showed
greater differences between IMD categories than those observed
in the adjusted analyses suggesting that the association observed
is confounded by other variable/s within the model. Positivity in
females varied by deprivation in a non-linear fashion.
In males, tests with a postcode identical to the clinic had
a lower positivity than those with a different postcode (AOR
0.60, 95% CI 0.40 to 0.88, data available in web table). For
females, differences observed in the crude analyses were no
longer signiﬁcant in the multivariate model, which suggests that
this association is confounded by other variable/s within the
model.
The distribution of positive tests was analysed by clinic type.
Positivity in general practice was 9.4% for males and 8.2% for
females. Community contraception services and youth services
had comparable or higher positivity, universities showed lower
positivity than general practice for both sexes, and military
showed lower positivity in males. Community contraception
services, youth services and general practice identiﬁed the
majority of positives for both males and female. In total, 44.0%
of positive males were identiﬁed through healthcare settings
compared with 60.8% for females.
DISCUSSION
In the fourth year of the NCSP, in the South East 1.0% of males
and 3.3% of females aged 15e24 were tested. Both testing
coverage and positivity varied with demographic factors, and
higher coverage therefore did not necessarily correspond with
a higher yield of positives. Low positivity was observed in
universities and in males aged 15e19 and males tested through
military settings. Although some non-healthcare settings such as
outreach and chlamydia screening ofﬁces (data available in web
tables) showed positivity comparable with general practice, it
may be difﬁcult to maintain regular screening in these settings,
and regular screening is essential for sustained reductions in
transmission.
This is the ﬁrst study describing the associations of coverage
and positivity in relation to deprivation and residential status at
a subnational level, and informs the planning of NCSP rollout in
contrasting demographic settings. By focusing on the contribu-
tion of various clinic types and their identiﬁcation of positives, it
adds to our understanding of the programme by clinic type and
setting overall.
The limitations of this study point to improvements that
need to be made in the collection of data, in order to assess the
Table 1 Tests from individuals under 25 screened in the South East
between March 2006 to April 2007 by demographic and geographic
variables and sex
Characteristics
Males Females
No of tests
(percentage
of total)
No of tests
(percentage
of total)
Total
6467 19675
Age group
<16 323 (5.0) 1951 (9.9)
16e19 3747 (57.9) 10320 (52.5)
20e24 2397 (37.1) 7404 (37.6)
Ethnicity
White 5169 (79.9) 16558 (84.2)
Black 248 (3.8) 418 (2.1)
Asian 50 (0.8) 147 (0.7)
Chinese 58 (0.9) 109 (0.6)
Other ethnic group 62 (1.0) 96 (0.5)
Mixed 145 (2.2) 395 (2.0)
Unknown 735 (11.4) 1952 (9.9)
Result
Positive 480 (7.4) 1727 (8.8)
Negative 5829 (90.1) 17376 (88.3)
Insufficient specimen 122 (1.9) 239 (1.2)
Other 36 (0.6) 333 (1.7)
Postcode
South East non-clinic postcode 3720 (57.5%) 16246 (82.6%)
Screen with clinic postcode 1816 (28.1%) 756 (3.8%)
Non-South East postcode 184 (2.8%) 255 (1.3%)
Unmappable postcodes 747 (11.6%) 2418 (12.3%)
Clinic type
Accident and emergency 10 (0.2) 19 (0.1)
Chlamydia screening office 267 (4.1) 260 (1.3)
Community contraception services 703 (10.9) 6871 (34.9)
General practice 875 (13.5) 3423 (17.4)
Gynaecology and obstetrics 4 (0.1) 540 (2.7)
Military 1200 (18.6) 257 (1.3)
Outreach 162 (2.5) 342 (1.7)
Pharmacy 39 (0.6) 139 (0.7)
Postal kit 214 (3.3) 695 (3.5)
Prison 165 (2.6) 24 (0.1)
Sexual-health services 35 (0.5) 67 (0.3)
Termination of pregnancy 2 (0.0) 584 (3.0)
University 1752 (27.1) 2136 (10.9)
Youth services 1039 (16.1) 4318 (21.9)
Setting
Healthcare 1833 (28.3) 11667 (59.3)
Non-healthcare 4634 (71.7) 8008 (40.7)
Urban/rural*
Urban 4513 (81.5) 15016 (88.3)
Rural 1023 (18.5) 1986 (11.7)
South East Indices of Multiple Deprivation categories*
1 (most deprived) 1242 (22.4) 6148 (36.2)
2 960 (17.3) 3812 (22.4)
3 912 (16.5) 2688 (15.8)
4 1200 (21.7) 2244 (13.2)
5 1222 (22.1) 2110 (12.4)
Four tests were removed because sex was either blank or incorrectly coded.
*Require mappable postcode, South East screens only.
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NCSP in future. We assumed that the postcode of residence
should not generally be identical to the clinic where the test was
done. In some areas, such tests appear to be over-represented,
especially for males and within military and university settings.
Further work is required to ascertain the true proportion of tests
where patient postcode should correctly be identical to clinic
postcode, since they render coverage analyses and thus
programme evaluation inaccurate. Where postcode of residence
Table 2 Number and percentage of total population screened and crude and adjusted incident rate ratios for testing
Characteristic
Males Females
Total
population
N (%)
total
Unadjusted
incident rate ratio
(95% CI)
Total
population N (%) total
Unadjusted
incident rate ratio
(95% CI)
Total*
523093 5451 (1.0) 496061 16510 (3.3)
Age group
15e19 271222 3356 (1.2) 1 255996 9995 (3.9) 1
20e24 251871 2095 (0.8) 0.67 (0.64 to 0.71) 240065 6515 (2.7) 0.69 (0.67 to 0.72)
Urban versus ruraly
Urban 424343 3101 (0.7) 1 408294 13972 (3.4) 1
Rural 98750 556 (0.6) 0.77 (0.70 to 0.84) 87767 1804 (2.1) 0.60 (0.57 to 0.63)
Indices of Multiple Deprivation categoryy
1 (most deprived) 119094 1098 (0.9) 1 121592 5671 (4.7) 1
2 113482 756 (0.7) 0.72 (0.66 to 0.79) 110768 3637 (3.3) 0.70 (0.68 to 0.73)
3 97225 555 (0.6) 0.62 (0.56 to 0.69) 89894 2496 (2.8) 0.60 (0.57 to 0.62)
4 99371 551 (0.6) 0.60 (0.54 to 0.67) 87898 2068 (2.4) 0.50 (0.48 to 0.53)
5 93921 697 (0.7) 0.80 (0.73 to 0.89) 85909 1904 (2.2) 0.48 (0.45 to 0.50)
*Only tests done in individuals aged 15e24 are included in the coverage analyses.
yOnly tests with South East non-clinic postcodes were included in the urban/rural and Indices of Multiple Deprivation univariate analyses (total number is 3657 for males and 15776 for females).
Table 3 Testing and positivity by demographic characteristics
Characteristic
Males Females
Tests
N
(% positive)
Crude OR
(95% CI)
Adjusted ORs
(95% CI) Tests
N
(% positive)
Crude OR
(95% CI)
Adjusted ORs
(95% CI)
Total
6465 480 (7.4) 19670 1727 (8.8)
Age group
<16 323 2 (0.6) 0.33 (0.18 to 0.59) 0.21 (0.10 to 0.44) 1951 21 (1.1) 0.56 (0.45 to 0.69) 0.46 (0.36 to 0.60)
16e19 3746 186 (5.0) 0.53 (0.45 to 0.64) 0.62 (0.49 to 0.79) 10317 854 (8.3) 1.05 (0.95 to 1.17) 1.04 (0.92 to 1.17)
20e24 2396 205 (8.6) 1 1 7402 563 (7.6) 1 1
Ethnicity
White 5167 379 (7.3) 1 1 16554 1530 (9.2) 1 1
Black 248 35 (14.1) 2.08 (1.43 to 3.01) 2.15 (1.40 to 3.29) 418 40 (9.6) 1.04 (0.75 to 1.45) 1.01 (0.69 to 1.50)
Asian 50 3 (6.0) 0.81 (0.25 to 2.60) 0.63 (0.19 to 2.09) 147 6 (4.1) 0.42 (0.18 to 0.95) 0.26 (0.08 to 0.82)
All other 207 16 (7.7) 1.06 (0.63 to 1.78) 0.67 (0.34 to 1.35) 491 43 (8.8) 0.94 (0.69 to 1.29) 1.00 (0.71 to 1.42)
Urban versus rural
Urban 4549 334 (7.3) 1 1 15001 1323 (8.8) 1 1
Rural 985 64 (6.5) 0.88 (0.66 to 1.16) 1.16 (0.84 to 1.61) 1997 146 (7.3) 0.81 (0.68 to 0.97) 0.84 (0.69 to 1.02)
Indices of Multiple Deprivation category
1 (most deprived) 1241 119 (9.6) 1 1 6148 562 (9.1) 1 1
2 960 95 (9.9) 1.04 (0.78 to 1.38) 1.06 (0.77 to 1.47) 3812 302 (7.9) 0.86 (0.74 to 0.99) 0.85 (0.73 to 1.00)
3 912 69 (7.6) 0.77 (0.57 to 1.05) 0.93 (0.65 to 1.33) 2688 264 (9.8) 1.08 (0.93 to 1.26) 1.09 (0.92 to 1.28)
4 1199 57 (4.8) 0.47 (0.34 to 0.65) 0.57 (0.38 to 0.85) 2244 194 (8.6) 0.94 (0.79 to 1.12) 0.93 (0.77 to 1.11)
5 1222 58 (4.7) 0.47 (0.34 to 0.65) 0.63 (0.43 to 0.92) 2106 147 (7.0) 0.75 (0.62 to 0.90) 0.84 (0.69 to 1.03)
Clinic type
General Practice 874 82 (9.4) 1 1 3421 279 (8.2) 1 1
Community contraceptive clinics 703 89 (12.7) 1.40 (1.02 to 1.92) 1.70 (1.17 to 2.48) 6871 673 (9.8) 1.22 (1.06 to 1.42) 1.27 (1.08 to 1.49)
Prison 165 21 (12.7) 1.41 (0.84 to 2.35) 1.26 (0.67 to 2.37) 24 0 (0)
Youth services 1038 105 (10.1) 1.09 (0.80 to 1.47) 1.24 (0.84 to 1.83) 4317 450 (10.4) 1.31 (1.12 to 1.53) 1.21 (1.00 to 1.46)
Military 1200 63 (5.3) 0.54 (0.38 to 0.75) 0.57 (0.37 to 0.88) 257 20 (7.8) 0.95 (0.59 to 1.52) 0.88 (0.48 to 1.62)
University 1752 52 (3.0) 0.30 (0.21 to 0.42) 0.33 (0.22 to 0.51) 2135 92 (4.3) 0.51 (0.40 to 0.65) 0.52 (0.40 to 0.68)
Other healthcare clinics 90 19 (21.1) 2.58 (1.48 to 4.50) 2.43 (1.19 to 4.95) 1348 98 (7.3) 0.88 (0.70 to 1.12) 0.88 (0.68 to 1.15)
Other non-healthcare clinics 643 49 (7.6) 0.80 (0.55 to 1.15) 0.90 (0.58 to 1.42) 1297 115 (8.9) 1.10 (0.87 to 1.38) 1.21 (0.95 to 1.56)
Setting
Healthcare 1832 211 (11.5) 1 11664 1050 (9.0) 1
Non-healthcare 4633 269 (5.8) 0.47 (0.39 to 0.57) 8006 677 (8.5) 0.93 (0.84 to 1.03)
Seven tests have been removed from this analysis, as the screening test result was either blank or incorrectly coded.
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is not complete or is incorrect, such tests cannot be analysed
with respect to deprivation and urban/rural classiﬁcation or at
any geographical area (without using a proxy measure such as
programme area). IMD and rural/urban classiﬁcation are derived
from postcodes, and any wrong assignment of individuals to
a postcode could bias all these analyses.
We calculated testing coverage using total population esti-
mates for the 15e24 age group. However, the target population
of NCSP is individuals under 25 that are sexually active, so our
estimates in this study are an underestimate of true testing
coverage. However, the Department of Health also measures
coverage of the programme using the 15e24 population as the
denominator, and so our method does allow for overall compar-
ison with data from the Department of Health. It is also possible
that some of the services classiﬁed as ‘youth services’ might have
been more appropriately described as ‘contraception services,’
and this may have led to somemisclassiﬁcation of tests by service
type.
We were not able to provide estimates of coverage by
ethnicity, due to limitations in the public health datasets
available to us at lower super output level and within settings.
We also did not examine interactions or effect modiﬁcation
which may be occurring between variables. Because IMD and
urban/rural were all derived from postcodes, this may confound
any associations observed between each of the variables and
either screening coverage or positivity.
These data indicate that chlamydia screening in the South
East of England needs to be better targeted, especially in males,
while increasing the volume of testing. Coverage, as elsewhere in
England,1 was considerably below modelling estimates of their
coverage required to achieve disease control,6 and below the
coverage achieved in the 1-year periods of the Department of
Health4 and ClaSS pilots of chlamydia screening.13 These focused
on primary care in order to achieve high coverage. The focus we
saw on large military and university settings, especially for
males, can generate a large number of tests, but with low posi-
tivity. These institutional settings also have a ﬁnite limit to the
amount of testing they can sustain, which, if targets are to be
met, would equate to a relatively small proportion of the overall
tests. In the South East, they appear to be targeted at groups of
young people at lower risk. A strategy that can give access to
both high numbers of the target population and a wide variety of
individuals needs to be developed. This will require further
engagement with general practice, contraceptive services and
youth clinics, all of which can deliver high numbers of tests and
demonstrate relatively high positivity compared with other
settings. It is often claimed that men underutilise general
practice, but consultation rates in 15e19-year-old and 20e24-
year-old males were 2.83 and 3.40 per person year, respectively, in
2007,14 suggesting that opportunistic testing in primary care
may be more realistic than is generally assumed.
Ongoing data analyses of the kind we demonstrate here,
describing the distribution of testing coverage and positivity,
will be required to provide continuous evaluation and highlight
areas where current targeting could be improved. Such analyses
can assist local and national programmes to improve their
strategy for the targeting of testing in order to improve equity of
coverage, increase testing volumes and detect a greater propor-
tion of chlamydia infections.
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Key messages
< Coverage in the fourth year of the National Chlamydia
Screening programme in the South East remains low in
both males and females (1.0% and 3.3% 15e24-year-olds
respectively).
< Testing is higher for more deprived areas for females but not
males.
< Positivity was lower in tests done through university clinics
and for males military clinics compared with general practice.
< Clinics within the healthcare settings have demonstrated, and
continue to demonstrate, that high volumes of testing can be
achieved with corresponding high positivity.
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